The price of the insulin more than doubled from 2002 to 2013.

Indianapolis-based Eli Lilly, along with two other European pharmaceutical companies, is facing a price-fixing lawsuit regarding its rapidly escalating insulin prices.

In a letter, Vermont Sen. Bernie Sanders and Maryland Rep. Elijah Cummings criticize three insulin manufacturers -- including Indianapolis-based Eli Lilly -- for skyrocketing insulin prices.